Latest filing published 29 Dec 2020 for RTW Biotech Opportunities Ltd.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +71.5%Entry US$1.23 · Close at T+365 US$2.11
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephanie Anne Sirota Revocable Trust re Stephanie Sirota: trading record in brief
Stephanie Anne Sirota Revocable Trust re Stephanie Sirota discloses dealings in RTW Biotech Opportunities Ltd to RNS (LSE). In total, 3 filings cover trades dated from 27 April 2020 to 23 December 2020.
No open-market sale appears; the market trades are 1 purchase worth €182k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 29 December 2020 with a transaction in RTW Biotech Opportunities Ltd. The most recent open-market purchase was published on 28 April 2020, 2,385 days ago. Typically, a trade is published a median of 6 days after it takes place. For comparison, UK MAR gives managers three business days to notify a trade. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Stephanie Anne Sirota Revocable Trust re Stephanie Sirota
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 494,004 sharesLondon Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3828301
- 169,000 sharesLondon Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3824934
- 169,000 shares@ US$1.165100.0% of flowLondon Stock Exchange, Specialist Fund SegmentISIN GG00BKTRRM22FCA-NSM:3578494Canonical exit: 26 Jul 2020 (T+90)
3 of 3 declarations